Guselkumab, a human interleukin‐23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52‐week, phase 3, multicenter, open‐label study

Generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP) are the rare and severe subtypes of psoriasis, which are often difficult to treat. The aim of this phase 3, open‐label study was to evaluate efficacy and safety of guselkumab, a human interleukin‐23 monoclonal antibody, in Japanes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Dermatol
Main Authors: Sano, Shigetoshi, Kubo, Hiroshi, Morishima, Hitomi, Goto, Ryosuke, Zheng, Richuan, Nakagawa, Hidemi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947137/
https://ncbi.nlm.nih.gov/pubmed/29569397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1346-8138.14294
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados